Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 43, 2013, Pages 17462-17467

  Cai, Zheqing ^a   Luo, Weibo ^a   Zhan, Huiwang ^a   Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac surgery; Cardioprotection; Coronary heart disease; Myocardial infarction

Indexed keywords

ACRIFLAVINE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ALLELE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CORONARY REPERFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMORAL ARTERY; HEART; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; HETEROZYGOTE; HINDLIMB; ISCHEMIC PRECONDITIONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REOXYGENATION;

CARDIAC SURGERY; CARDIOPROTECTION; CORONARY HEART DISEASE; MYOCARDIAL INFARCTION;

ACRIFLAVINE; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; CELL LINE; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; INTERLEUKIN-10; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, KNOCKOUT; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84886435248     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317158110     Document Type: Article

References (35)

1. Roger VL, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2012) Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation 125(1):e2-e220.
2. Nallamothu BK, Bradley EH, Krumholz HM (2007) Time to treatment in primary percutaneous coronary intervention. N Engl J Med 357(16):1631-1638.
3. Braunwald E, Kloner RA (1985) Myocardial reperfusion: A double-edged sword? J Clin Invest 76(5):1713-1719.
4. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion - From mechanism to translation. Nat Med 17(11):1391-1401.
5. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124-1136.
6. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87(3):893-899.
7. Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD (1996) Myocardial protection by brief ischemia in noncardiac tissue. Circulation 94(9):2193-2200.
8. Birnbaum Y, Hale SL, Kloner RA (1997) Ischemic preconditioning at a distance: Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96(5): 1641-1646.
9. Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B (1997) Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol 273(4 Pt 2): H1707-H1712.
10. Ateş E, et al. (2002) Renal protection by brief liver ischemia in rats. Transplantation 74(9):1247-1251.
11. Kharbanda RK, et al. (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106(23):2881-2883.
12. Thielmann M, et al. (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: A single-centre randomised, double-blind, controlled trial. Lancet 382(9892):597-604.
13. Schwartz Longacre L, et al.; National Heart, Lung, and Blood Institute, National Institutes of Health (2011) New horizons in cardioprotection: Recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 124(10): 1172-1179.
14. Cai ZP, Parajuli N, Zheng X, Becker L (2012) Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 107(4):277.
15. Prabhakar NR, Semenza GL (2012) Adaptive and maladaptive responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 92(3):967-1003.
16. 2 tension. Proc Natl Acad Sci USA 92(12):5510-5514.
17. 2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 12(2):149-162.
18. Cai Z, et al. (2008) Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 α. Cardiovasc Res 77(3):463-470.
19. Eckle T, Köhler D, Lehmann R, El Kasmi K, Eltzschig HK (2008) Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation 118(2):166-175.
20. Bosch-Marcé M, et al. (2007) Effects of aging and HIF-1 activity on angiogenic cell mobilization and recovery of perfusion following limb ischemia. Circ Res 101(12): 1310-1318.
21. Kelly BD, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93(11):1074-1081.
22. Manalo DJ, et al. (2005) Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105(2):659-669.
23. Lee K, et al. (2009) Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci USA 106(42):17910-17915.
24. Semenza GL, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxiainducible factor 1. J Biol Chem 271(51):32529-32537.
25. Semenza GL (2013) Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol, 10.1146/annurev-physiol-021113-170322.
26. Sharma S, et al. (2011) IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 1373:189-194.
27. Mocanu MM, Bell RM, Yellon DM (2002) PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34(6):661-668.
28. Davidson SM, et al. (2013) Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol 108(5):377.
29. Ceradini DJ, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858-864.
30. Cai Z, et al. (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108(1):79-85.
31. Sarkar K, et al. (2012) Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc Natl Acad Sci USA 109(26):10504-10509.
32. Eckle T, et al. (2012) Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18(5): 774-782.
33. Rahman IA, et al. (2010) Remote ischemic preconditioning in human coronary artery bypass surgery: From promise to disappointment? Circulation 122(Suppl 11)S53-S59.
34. Luo W, Chang R, Zhong J, Pandey A, Semenza GL (2012) Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression. Proc Natl Acad Sci USA 109(49):E3367-E3376.
35. Luo W, et al. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxiainducible factor 1. Cell 145(5):732-744.